Literature DB >> 2654284

No specific association between primary biliary cirrhosis and bacteriuria?

A Floreani1, M F Bassendine, H Mitchison, R Freeman, O F James.   

Abstract

160 consecutive patients with primary biliary cirrhosis (PBC) (M:F, 13:147; total samples 286), 140 patients with other chronic liver disease (CLD) (M:F, 75:65; total samples 200), and 28 patients with primary Sjögren's syndrome (all F; total samples 37), were examined for bacteriuria over 6 months by midstream urine (MSU) examination. The overall prevalence of bacteriuria in PBC was 11.2% (7.5% on first MSU), in CLD 12.1% (10.7% on first MSU), 18.4% in the 65 female CLD patients, 10.7% in Sjögren's syndrome patients (3.5% on first MSU). The prevalence of bacteriuria was related to the age of the patient (P less than 0.02) in PBC and to the presence or absence of cirrhosis in both PBC and CLD (P less than 0.02). There was no difference in the prevalence of bacteriuria between PBC and CLD patients taken as a whole or among females alone, cirrhotic or non-cirrhotic groups. In a second prospective study of the cumulative incidence of bacteriuria in PBC versus CLD and Sjögren's no significant differences between groups was observed but among 29 PBC patients the cumulative proportion of positive tests for bacteriuria after 5 months (monthly testing) was 34%. We conclude that there is no specific association between PBC and bacteriuria compared with the prevalence of bacteriuria in other CLD.

Entities:  

Mesh:

Year:  1989        PMID: 2654284     DOI: 10.1016/0168-8278(89)90008-1

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  9 in total

Review 1.  Pathogen infections and primary biliary cholangitis.

Authors:  A Tanaka; P S C Leung; M E Gershwin
Journal:  Clin Exp Immunol       Date:  2018-09-17       Impact factor: 4.330

Review 2.  Aetiology and pathophysiology of chronic liver disorders.

Authors:  J Schölmerich; A Holstege
Journal:  Drugs       Date:  1990       Impact factor: 9.546

3.  Urinary tract infections in primary biliary cirrhosis and other chronic liver diseases.

Authors:  J O'Donohue; M R Workman; N Rolando; M Yates; J Philpott-Howard; R Williams
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-10       Impact factor: 3.267

Review 4.  Environmental factors in primary biliary cirrhosis.

Authors:  Brian D Juran; Konstantinos N Lazaridis
Journal:  Semin Liver Dis       Date:  2014-07-24       Impact factor: 6.115

5.  Natural history of bacteriuria in women with primary biliary cirrhosis and the effect of antimicrobial therapy in symptomatic and asymptomatic groups.

Authors:  P Butler; J M Hamilton-Miller; N McIntyre; A K Burroughs
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

6.  Potential Roles for Infectious Agents in the Pathophysiology of Primary Biliary Cirrhosis: What's New?

Authors:  Daniel S Smyk; Eirini I Rigopoulou; Dimitrios P Bogdanos
Journal:  Curr Infect Dis Rep       Date:  2013-02       Impact factor: 3.725

Review 7.  Popular and unpopular infectious agents linked to primary biliary cirrhosis.

Authors:  Andreas L Koutsoumpas; Stephen Kriese; Eirini I Rigopoulou
Journal:  Auto Immun Highlights       Date:  2012-10-23

Review 8.  Infectome: a platform to trace infectious triggers of autoimmunity.

Authors:  Dimitrios P Bogdanos; Daniel S Smyk; Pietro Invernizzi; Eirini I Rigopoulou; Miri Blank; Shideh Pouria; Yehuda Shoenfeld
Journal:  Autoimmun Rev       Date:  2012-12-22       Impact factor: 9.754

Review 9.  Tracing environmental markers of autoimmunity: introducing the infectome.

Authors:  Dimitrios P Bogdanos; Daniel S Smyk; Pietro Invernizzi; Eirini I Rigopoulou; Miri Blank; Lazaros Sakkas; Shideh Pouria; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.